What is BlackRock Health Sciences Trust (BME)?

BlackRock Health Sciences Trust (BME) is a stock in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of BME?

The current price of BME is $46.74. Prices are updated in real time on Stocks360.

What is BME's price-to-earnings (PE) ratio?

BME's trailing twelve-month PE ratio is 5.81, based on current price and earnings per share data available on Stocks360.

What is BME's market capitalization?

BME's market capitalization is $604,072,434.00, placing it in the small-cap tier.

Does BME pay a dividend?

Yes. BME has a trailing twelve-month dividend yield of 0.07%. Dividend data is sourced from financial market providers and displayed on Stocks360.

BlackRock Health Sciences Trust (BME)

Stock analysis · NYSE · Financial Services · Asset Management

$46.74

Market Cap

$604.07M

PE (TTM)

5.81

EPS (TTM)

N/A

Dividend Yield

6.73%

Beta

0.60

Day Range

$46.33 – $46.75

52-wk Range

$37.51 – $46.75

Avg Volume

N/A

Volume

50.76K

BlackRock Health Sciences Trust (BME) is a publicly traded company in the Financial Services sector. Latest price: $46.74. Market cap $604.07M. Trailing PE 5.81. Dividend yield 6.73%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $38.27 2026-10-29 · $46.74 (+22.13%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	5.81×
P/S (TTM)	11.29×
P/B	1.06×
PEG	0.01×
P/FCF (TTM)	-63.95×
EV / EBITDA	5.81×
EV / Sales	11.30×
Earnings Yield	17.22%
Free Cash Flow Yield	-1.56%
Dividend Yield	6.73%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$604.76M
Revenue (TTM)	$53.50M
Net Income (TTM)	$104.01M
Free Cash Flow (TTM)	-$9.41M
Net Debt	$687.99K
Working Capital	$22.31M
Gross Margin	89.50%
Operating Margin	194.48%
Net Margin	194.41%
Return on Equity	18.25%
Return on Invested Capital	18.11%